Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -29.50% is 24% above its 5-year average of -38.95%, near the high end of its 5-year range (-95.23%–-16.10%).
As of the fiscal period ended Tuesday, June 30, 2026. 22.44% above its 12-month average of -38.03%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -29.50%.
RETURN ON INVESTED CAPITAL (ROIC)
-29.50%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-38.03%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-39.51%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-38.95%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+22.44%
CURRENT VS 3Y AVG
+25.35%
CURRENT VS 5Y AVG
+24.27%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.77%
median of 761 covered companies
CURRENT VS SECTOR MEDIAN
+15.17%
vs the sector median at left
Sight Sciences, Inc.
Market Cap
$468.74M
Return on Invested Capital (ROIC)
-29.50%
TTM Avg
-38.03%
3Y Avg
-39.51%
5Y Avg
-38.95%
Market Cap
$469.68M
Return on Invested Capital (ROIC)
-27.22%
TTM Avg
-25.30%
3Y Avg
-27.88%
5Y Avg
-30.72%
Market Cap
$471.36M
Return on Invested Capital (ROIC)
6.95%
TTM Avg
6.49%
3Y Avg
4.50%
5Y Avg
4.55%
Market Cap
$472.03M
Return on Invested Capital (ROIC)
-13.15%
TTM Avg
-33.80%
3Y Avg
-80.16%
5Y Avg
-71.70%
Market Cap
$475.60M
Return on Invested Capital (ROIC)
-1.08%
TTM Avg
-7.18%
3Y Avg
-14.01%
5Y Avg
-19.76%
Market Cap
$459.39M
Return on Invested Capital (ROIC)
8.75%
TTM Avg
20.32%
3Y Avg
26.86%
5Y Avg
29.17%
Market Cap
$478.01M
Return on Invested Capital (ROIC)
-2.19%
TTM Avg
-24.50%
3Y Avg
-28.59%
5Y Avg
-24.45%
Market Cap
$486.35M
Return on Invested Capital (ROIC)
18.26%
TTM Avg
19.81%
3Y Avg
16.87%
5Y Avg
7.92%
Market Cap
$448.71M
Return on Invested Capital (ROIC)
-100.87%
TTM Avg
-63.16%
3Y Avg
-52.79%
5Y Avg
-48.48%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | $468.74M | -29.50% | -38.03% | -39.51% | -38.95% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $469.68M | -27.22% | -25.30% | -27.88% | -30.72% |
| Kamada Ltd. (KMDA)vs › | $471.36M | 6.95% | 6.49% | 4.50% | 4.55% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.03M | -13.15% | -33.80% | -80.16% | -71.70% |
| Cerus Corporation (CERS)vs › | $475.60M | -1.08% | -7.18% | -14.01% | -19.76% |
| NRC Health (NRC)vs › | $459.39M | 8.75% | 20.32% | 26.86% | 29.17% |
| Arvinas, Inc. (ARVN)vs › | $478.01M | -2.19% | -24.50% | -28.59% | -24.45% |
| Puma Biotechnology, Inc. (PBYI)vs › | $486.35M | 18.26% | 19.81% | 16.87% | 7.92% |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $448.71M | -100.87% | -63.16% | -52.79% | -48.48% |
| Ovid Therapeutics Inc. (OVID)vs › | $446.11M | -26.29% | -52.77% | -46.93% | -45.09% |
ROIC
-29.5%
ROE
-56.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -29.50% |
| 2026-03-31 | -37.40% |
| 2025-12-31 | -35.58% |
| 2025-09-30 | -43.44% |
| 2025-06-30 | -44.24% |
| 2025-03-31 | -42.25% |
| 2024-12-31 | -39.67% |
| 2024-09-30 | -38.30% |
| 2024-06-30 | -38.04% |
| 2024-03-31 | -37.83% |
| 2023-12-31 | -36.57% |
| 2023-09-30 | -38.95% |
| 2023-06-30 | -41.84% |
| 2023-03-31 | -43.71% |
| 2022-12-31 | -43.00% |
| 2022-09-30 | -39.27% |
| 2022-06-30 | -32.58% |
| 2022-03-31 | -25.15% |
| 2021-12-31 | -19.30% |
| 2021-09-30 | -16.10% |
| 2021-06-30 | -95.23% |
| 2021-03-31 | -68.57% |
| 2020-12-31 | -50.70% |
